SA makes vaccine history with homegrown cholera trials

A major milestone for South African science, local biotech firm Biovac has launched clinical trials for the country’s first fully home-developed oral cholera vaccine. Approved by Sahpra, it’s the first vaccine to undergo end-to-end development in South Africa in over 50 years. The SAMRC, led by Professor Glenda Gray, will oversee the trials. Biovac CEO Dr Morena Makhoana says the breakthrough could strengthen Africa’s fight against infectious diseases. Phemelo speaks to Chief Scientific Officer at the South African Medical Research Council, Professor Glenda Gray for more insight.